Clinical trials recruiting in Stavanger, Norway

Phase breakdown

Conditions recruiting in Stavanger, Norway

Recruiting trials in Stavanger, Norway

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
  NCT06966700 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
  NCT06944587 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
  NCT06119581 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
  NCT06077760 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
  NCT07438496 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
  NCT07522073 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
  NCT06885034 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
  NCT05388461 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
  NCT01762813 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
  NCT06488482 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Blood-based Biomarkers for Diagnosis of Alzheimer's
  NCT05187819 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 100 Years · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
  NCT06362707 · Phase: Phase 2 · Ages: 50 Years to 100 Years · Sex: All (male and female)
• Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
  NCT05448547 · Phase: Phase 3 · Ages: 75 Years and older · Sex: Male
• Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
  NCT03889743 · Phase: Phase 4 · Ages: 3 Months to 23 Months · Sex: All (male and female)
• Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis
  NCT06084364 · Phase: Phase 4 · Ages: 40 Years to 85 Years · Sex: All (male and female)
• Management of Patients With Heart Failure at Home After Hospital Discharge
  NCT06576752 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Monitoring of Chronic Conditions in Breast Cancer
  NCT05587777 · Phase: Not specified · Ages: 19 Years to 80 Years · Sex: Female
• Partial Breast Versus no Irradiation for Women With Early Breast Cancer
  NCT03646955 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: Female
• Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
  NCT07145307 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 18 Years · Sex: All (male and female)
• ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
  NCT03903835 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
  NCT05679024 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
  NCT05855200 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• The Key to Integrated Trauma Treatment in Psychosis Trial
  NCT06608706 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female)
• The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
  NCT05634889 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Thrombolysis in Factor Xa-inhibitors Trial
  NCT06878066 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Stavanger, Norway?

28 recruiting trials have at least one study site in Stavanger, Norway.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.